Published in Arch Dermatol Res on January 01, 1987
Human pro alpha 1(I) collagen: cDNA sequence for the C-propeptide domain. Nucleic Acids Res (1988) 1.04
A novel organotypic model mimics the tumor microenvironment. Am J Pathol (2009) 1.01
Expression of mRNAs coding for the alpha 1 chain of type XIII collagen in human fetal tissues: comparison with expression of mRNAs for collagen types I, II, and III. J Cell Biol (1989) 0.93
Transcriptional control mechanisms for the expression of type I collagen genes. Ann Rheum Dis (1991) 0.86
Increased collagen synthesis in psoriasis in vivo. Arch Dermatol Res (1995) 0.84
In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds. J Clin Invest (1993) 0.83
Expression of mRNAs for type I and type III procollagens in serous ovarian cystadenomas and cystadenocarcinomas. Am J Pathol (1996) 0.82
Axonal regeneration into chronically denervated distal stump. 2. Active expression of type I collagen mRNA in epineurium. Acta Neuropathol (1995) 0.81
Comparison of the effects of dexamethasone and 13-cis-retinoic acid on connective tissue biosynthesis in human skin fibroblasts. Arch Dermatol Res (1989) 0.80
Interleukin-1 beta prevents the stimulatory effect of transforming growth factor-beta on collagen gene expression in human skin fibroblasts. Biochem J (1990) 0.79
Characterization of excessive collagen production during development of pulmonary fibrosis induced by chronic silica inhalation in rats. Br J Exp Pathol (1989) 0.79
Localization of precursor proteins and mRNA of type I and III collagens in usual interstitial pneumonia and sarcoidosis. J Mol Histol (2006) 0.77
New lethal disease involving type I and III collagen defect resembling geroderma osteodysplastica, De Barsy syndrome, and Ehlers-Danlos syndrome IV. J Med Genet (1998) 0.76
Collagen biosynthesis and type I and type III procollagen mRNA in lichen sclerosus et atrophicus. Arch Dermatol Res (1990) 0.75
Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J (1999) 4.85
Predisposition to familial osteoarthrosis linked to type II collagen gene. Lancet (1989) 2.43
Localization of types I, II, and III collagen mRNAs in developing human skeletal tissues by in situ hybridization. J Cell Biol (1987) 2.41
Characterization of primary cultures of chondrocytes from type II collagen/beta-galactosidase transgenic mice. Matrix Biol (1994) 2.12
Matrix metalloproteinases in wound repair (review). Int J Mol Med (2000) 1.98
Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells. Cancer Res (1998) 1.83
A standardized experimental fracture in the mouse tibia. J Orthop Res (1993) 1.75
Mouse type II collagen gene. Complete nucleotide sequence, exon structure, and alternative splicing. J Biol Chem (1991) 1.67
Specific hybridization probes for mouse type I, II, III and IX collagen mRNAs. Biochim Biophys Acta (1991) 1.67
Matrix metalloproteinases in tumor invasion. Cell Mol Life Sci (2000) 1.66
Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am J Pathol (1997) 1.66
Integrin alpha2beta1 mediates isoform-specific activation of p38 and upregulation of collagen gene transcription by a mechanism involving the alpha2 cytoplasmic tail. J Cell Biol (1999) 1.65
The B subunit of a rat heteromeric CCAAT-binding transcription factor shows a striking sequence identity with the yeast Hap2 transcription factor. Proc Natl Acad Sci U S A (1990) 1.63
Integrin alpha 2 beta 1 is a positive regulator of collagenase (MMP-1) and collagen alpha 1(I) gene expression. J Biol Chem (1995) 1.56
Stage-and tissue-specific expression of a Col2a1-Cre fusion gene in transgenic mice. Matrix Biol (2001) 1.55
Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase. J Cell Sci (2000) 1.50
Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways. J Biol Chem (1998) 1.49
Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. Dev Dyn (1997) 1.44
p38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression. Mol Cell Biol (2001) 1.43
Reduced amounts of cartilage collagen fibrils and growth plate anomalies in transgenic mice harboring a glycine-to-cysteine mutation in the mouse type II procollagen alpha 1-chain gene. Proc Natl Acad Sci U S A (1991) 1.37
Induction of collagenase-3 (MMP-13) expression in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase. J Biol Chem (1999) 1.37
Construction and partial characterization of two recombinant cDNA clones for procollagen from chicken cartilage. Nucleic Acids Res (1982) 1.35
Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur J Biochem (1996) 1.35
Human collagenase-3 is expressed in malignant squamous epithelium of the skin. J Invest Dermatol (1997) 1.34
Transforming growth factor-beta induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase. J Biol Chem (1999) 1.30
The mouse collagen X gene: complete nucleotide sequence, exon structure and expression pattern. Biochem J (1993) 1.28
Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. J Invest Dermatol (1997) 1.26
Normal long bone growth and development in type X collagen-null mice. Nat Genet (1994) 1.26
Interleukin-1 increases collagen production and mRNA levels in cultured skin fibroblasts. Biochim Biophys Acta (1987) 1.25
Enhanced expression of TGF-beta and c-fos mRNAs in the growth plates of developing human long bones. Development (1988) 1.25
Identification of fibroblasts responsible for increased collagen production in localized scleroderma by in situ hybridization. J Invest Dermatol (1988) 1.21
A metaphyseal defect model of the femur for studies of murine bone healing. Bone (2001) 1.19
Mouse cathepsin K: cDNA cloning and predominant expression of the gene in osteoclasts, and in some hypertrophying chondrocytes during mouse development. FEBS Lett (1996) 1.18
Chondrodysplasia in transgenic mice harboring a 15-amino acid deletion in the triple helical domain of pro alpha 1(II) collagen chain. J Cell Biol (1992) 1.16
Localization of the expression of types I, III, and IV collagen, TGF-beta 1 and c-fos genes in developing human calvarial bones. Dev Biol (1988) 1.15
Collagenase 3 (matrix metalloproteinase 13) gene expression by HaCaT keratinocytes is enhanced by tumor necrosis factor alpha and transforming growth factor beta. Cell Growth Differ (1997) 1.12
Characterization of trimethoprim resistance by use of probes specific for transposon Tn7. Antimicrob Agents Chemother (1984) 1.10
Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas. Am J Pathol (1999) 1.10
Systemic versus cartilage-specific expression of a type II collagen-specific T-cell epitope determines the level of tolerance and susceptibility to arthritis. Proc Natl Acad Sci U S A (1996) 1.10
Evaluation of transforming growth factor beta and type I procollagen gene expression in fibrotic skin diseases by in situ hybridization. J Invest Dermatol (1990) 1.09
Expression of collagenase-3 (matrix metalloproteinase-13) in transitional-cell carcinoma of the urinary bladder. Int J Cancer (2000) 1.08
Construction of a human pro alpha 1(III) collagen cDNA clone and localization of type III collagen expression in human fetal tissues. Matrix (1989) 1.08
Developmental expression of a type II collagen/beta-galactosidase fusion gene in transgenic mice. Dev Dyn (1995) 1.06
Role of cathepsin K in normal joints and in the development of arthritis. Curr Drug Targets (2007) 1.06
A role for decorin in the structural organization of periodontal ligament. Lab Invest (2000) 1.06
Differential regulation of interstitial collagenase (MMP-1) gene expression by ETS transcription factors. Oncogene (1997) 1.06
Accelerated turnover of metaphyseal trabecular bone in mice overexpressing cathepsin K. J Bone Miner Res (2001) 1.05
Comparative effects of interleukin-1 and tumor necrosis factor-alpha on collagen production and corresponding procollagen mRNA levels in human dermal fibroblasts. J Invest Dermatol (1991) 1.05
Human pro alpha 1(I) collagen: cDNA sequence for the C-propeptide domain. Nucleic Acids Res (1988) 1.04
Localization of type I and III collagen and fibronectin production in injured gastrocnemius muscle. Lab Invest (1991) 1.04
Expression of Sox9 and type IIA procollagen during attempted repair of articular cartilage damage in a transgenic mouse model of osteoarthritis. Arthritis Rheum (2001) 1.03
Assembly of cartilage collagen fibrils is disrupted by overexpression of normal type II collagen in transgenic mice. Proc Natl Acad Sci U S A (1993) 1.02
Histomorphometric and molecular biologic comparison of bioactive glass granules and autogenous bone grafts in augmentation of bone defect healing. J Biomed Mater Res (1997) 1.01
Increased type I collagen mRNA levels in cultured scleroderma fibroblasts. Biochim Biophys Acta (1984) 1.01
Analysis of aggrecan and tenascin gene expression in mouse skeletal tissues by northern and in situ hybridization using species specific cDNA probes. Biochim Biophys Acta (1994) 1.01
Identification of messenger RNA for human type II collagen. FEBS Lett (1984) 1.01
Expression of human macrophage metalloelastase (MMP-12) by tumor cells in skin cancer. J Invest Dermatol (2000) 1.01
Antisense RNA inhibition of cathepsin L expression reduces tumorigenicity of malignant cells. Eur J Cancer (2000) 1.00
Up-regulation of cartilage oligomeric matrix protein at the onset of articular cartilage degeneration in a transgenic mouse model of osteoarthritis. Arthritis Rheum (2000) 0.99
Activation of tissue inhibitor of metalloproteinases-3 (TIMP-3) mRNA expression in scleroderma skin fibroblasts. J Invest Dermatol (1998) 0.99
Expression of human collagenase-3 (MMP-13) by fetal skin fibroblasts is induced by transforming growth factor beta via p38 mitogen-activated protein kinase. FASEB J (2001) 0.98
Collagenase-3 (matrix metalloproteinase-13) expression is induced in oral mucosal epithelium during chronic inflammation. Am J Pathol (1998) 0.98
Differential expression of myc, max and RB1 genes in human gliomas and glioma cell lines. Br J Cancer (1994) 0.98
Human TIMP-3 is expressed during fetal development, hair growth cycle, and cancer progression. J Histochem Cytochem (1998) 0.98
Expression of mRNAs for collagens and other matrix components in dedifferentiating and redifferentiating human chondrocytes in culture. FEBS Lett (1989) 0.96
Synthesis of underpolymerized hyaluronic acid by fibroblasts cultured from rheumatoid and non-rheumatoid synovitis. Rheumatol Int (1982) 0.96
Conservation of the sizes of 53 introns and over 100 intronic sequences for the binding of common transcription factors in the human and mouse genes for type II procollagen (COL2A1). Biochem J (1995) 0.96
Expression of the myc proto-oncogenes in developing human fetal brain. Oncogene (1990) 0.95
Molecular biology and pathology of human elastin. Biochem Soc Trans (1991) 0.95
Determination of the single polyadenylation site of the human pro alpha 1(II) collagen gene. Nucleic Acids Res (1987) 0.95
Cathepsin expression during skeletal development. Biochim Biophys Acta (1999) 0.95
Enhancement of fibroblast collagenase-1 (MMP-1) gene expression by tumor promoter okadaic acid is mediated by stress-activated protein kinases Jun N-terminal kinase and p38. Matrix Biol (1998) 0.94
Coordinate patterns of expression of type I and III collagens during mouse development. Matrix Biol (1995) 0.94
Regulation of extracellular matrix genes during fracture healing in mice. Clin Orthop Relat Res (1993) 0.94
Structural analysis of the regulatory elements of the type-II procollagen gene. Conservation of promoter and first intron sequences between human and mouse. Biochem J (1992) 0.94
Elevated pro alpha 2(I) collagen mRNA levels in cultured scleroderma fibroblasts result from an increased transcription rate of the corresponding gene. FEBS Lett (1987) 0.93
Activation of type I collagen genes in cultured scleroderma fibroblasts. J Cell Biochem (1985) 0.93
Expression of mRNAs coding for the alpha 1 chain of type XIII collagen in human fetal tissues: comparison with expression of mRNAs for collagen types I, II, and III. J Cell Biol (1989) 0.93
Expression of cathepsins B, H, K, L, and S and matrix metalloproteinases 9 and 13 during chondrocyte hypertrophy and endochondral ossification in mouse fracture callus. Calcif Tissue Int (2000) 0.93
Lifelong voluntary joint loading increases osteoarthritis in mice housing a deletion mutation in type II procollagen gene, and slightly also in non-transgenic mice. Ann Rheum Dis (2002) 0.92
In situ localization of collagen production by chondrocytes and osteoblasts in fracture callus. J Bone Joint Surg Am (1989) 0.92
Expression and activity of matrix metalloproteinase-2 and -9 in experimental granulation tissue. APMIS (2000) 0.92
Type X collagen, a natural component of mouse articular cartilage: association with growth, aging, and osteoarthritis. Arthritis Rheum (1998) 0.92
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas. APMIS (2001) 0.92
Autoimmune recognition of cartilage collagens. Ann Med (1993) 0.91